Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Nanobiotix

NBTX
Current price
4.05 USD -0.13 USD (-3.11%)
Last closed 3.91 USD
ISIN US63009J1079
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 199 927 552 USD
Yield for 12 month -30.71 %
1Y
3Y
5Y
10Y
15Y
NBTX
21.11.2021 - 28.11.2021

Nanobiotix S.A., a clinical-stage biotechnology, focuses on developing product candidates for the treatment of cancer and other unmet medical needs. Its lead product candidate is NBTXR3, a sterile aqueous suspension of crystalline hafnium oxide nanoparticles used for the treatment of soft tissue sarcoma, head and neck cancers, liver cancers, prostate cancer, pancreatic cancer, esophageal cancer, rectal cancer, and non-small cell lung cancer. The company has a partnership with Lian Oncology Limited to develop and commercialize NBTXR3 in Greater China, South Korea, Singapore, and Thailand. Nanobiotix S.A. was incorporated in 2003 and is headquartered in Paris, France. Address: 60 rue de Wattignies, Paris, France, 75012

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

11.19 USD

P/E ratio

Dividend Yield

Current Year

+32 035 726 USD

Last Year

+5 090 246 USD

Current Quarter

+4 950 094 USD

Last Quarter

+4 950 094 USD

Current Year

+32 035 726 USD

Last Year

+4 040 436 USD

Current Quarter

+4 950 094 USD

Last Quarter

+4 950 094 USD

Key Figures NBTX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -22 295 000 USD
Operating Margin TTM -253.32 %
PE Ratio
Return On Assets TTM -22.02 %
PEG Ratio
Return On Equity TTM -198.69 %
Wall Street Target Price 11.19 USD
Revenue TTM 42 204 000 USD
Book Value -0.46 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 182.1 %
Dividend Yield
Gross Profit TTM 4 776 000 USD
Earnings per share -0.79 USD
Diluted Eps TTM -0.79 USD
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY
Profit Margin -79.31 %

Dividend Analytics NBTX

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History NBTX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation NBTX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE 48.3092
Enterprise Value Revenue 4.7009
Price Sales TTM 4.7372
Enterprise Value EBITDA -2.447
Price Book MRQ 65.0172

Financials NBTX

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators NBTX

For 52 weeks

4.04 USD 8.96 USD
50 Day MA 4.92 USD
Shares Short Prior Month 33 298
200 Day MA 5.76 USD
Short Ratio 2.5
Shares Short 30 634
Short Percent 0.08 %